Abstract
Author response: Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have